Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$669K Buy
1,902
+77
+4% +$27.4K 0.23% 118
2025
Q4
$597K Buy
1,825
+22
+1% +$6.98K 0.21% 105
2025
Q3
$519K Buy
1,803
+12
+0.7% +$3.48K 0.2% 104
2025
Q2
$558K Hold
1,791
0.26% 86
2025
Q1
$558K Sell
1,791
-283
-14% -$83.6K 0.26% 86
2024
Q4
$541K Buy
2,074
+83
+4% +$24.6K 0.24% 95
2024
Q3
$642K Buy
1,991
+58
+3% +$19K 0.29% 85
2024
Q2
$604K Buy
1,933
+40
+2% +$11.8K 0.29% 81
2024
Q1
$538K Buy
1,893
+241
+15% +$70.5K 0.26% 96
2023
Q4
$476K Buy
+1,652
New +$450K 0.24% 104
2023
Q3
Sell
-1,176
Closed -$261K 62
2023
Q2
$261K Buy
1,176
+94
+9% +$21.8K 0.14% 141
2023
Q1
$262K Sell
1,082
-491
-31% -$121K 0.15% 144
2022
Q4
$425K Buy
1,573
+405
+35% +$109K 0.24% 103
2022
Q3
$273K Sell
1,168
-30
-3% -$7.27K 0.17% 117
2022
Q2
$292K Buy
1,198
+1
+0.1% +$245 0.18% 118
2022
Q1
$289K Buy
1,197
+1
+0.1% +$230 0.15% 113
2021
Q4
$278K Buy
+1,196
New +$252K 0.16% 98

Other funds holding AMGN

Saxon Interests's AMGN Position: Q1 2026 in Review

Saxon Interests increased its Amgen (AMGN) stake by 4.2% in Q1 2026, buying an estimated $27.4K and bringing the position to 1,902 shares worth $669K. The position accounts for 0.23% of the portfolio, ranked #118.

Saxon Interests first reported a position in AMGN in Q4 2021 and has held it in 17 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Saxon Interests held 1,902 shares of Amgen worth $669K as of Q1 2026.
  • Saxon Interests bought 77 Amgen shares in Q1 2026, an estimated $27.4K.
  • Amgen made up 0.23% of Saxon Interests's portfolio in Q1 2026, its #118 holding.
  • Saxon Interests first reported a position in Amgen in Q4 2021 and has held it in 17 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Saxon Interests's 13F filing for Q1 2026, filed 29 Apr 2026.